Journal: bioRxiv
Article Title: Cell-specific delivery of GJB2 restores auditory function in mouse models of DFNB1 deafness and mediates appropriate expression in NHP cochlea
doi: 10.1101/2024.12.24.630240
Figure Lengend Snippet: a. Distribution of GJB2 ( magenta ) in Gjb2 Pfl/Pfl , Cre- control mouse cochlea ( left ) and Gjb2 Pfl/Pfl , Cre+ cochlea (right) at P6. In Gjb2 Pfl/Pfl , Cre- mice, GJB2 was observed in Deiters’ cells, Hensen’s cells, Claudius cells, pillar cells, border cells, the epithelium of the inner and outer sulcus and the root cells of spiral prominence; in fibrocytes in the lateral wall and spiral limbus; and in basal and intermediate cells in the stria vascularis. Hair cells, labeled with an antibody to parvalbumin (PV; yellow) did not express Gjb2 in control cochleas. In Gjb2 Pfl/Pfl , Cre+ conditional knockout mice at P6, anti-GJB2 labeling detected no signal hair cells or epithelial cells in the organ of Corti. b. At P6, scanning electron microscopy of hair cells showed normal bundle morphology in both Gjb2 Pfl/Pfl , Cre+ conditional knockout mice and Gjb2 Pfl/Pfl , Cre- controls. c. Distribution at P30 of GJB2 in Gjb2 Pfl/Pfl , Cre- ( left ) and Gjb2 Pfl/Pfl , Cre+ (right) mouse cochleas. Conditional knockout mice had developed degeneration of the organ of Corti by P30. d. Exogenous (vector-delivered) mmGJB2.HA expression in P30 Gjb2 Pfl/Pfl , Cre+ conditional knockout mouse cochlea. Hair cells did not express mmGJB2.HA. It appeared in the epithelium of the inner and outer sulcus and the root cells of the spiral prominence, fibrocytes type I, II and V of the lateral wall and fibrocytes of the spiral limbus and strial cells, and these cells survived to at least P30. Hair cells, missing at P30 in untreated Gjb2 Pfl/Pfl , Cre+ mice, were present in the vector-treated cochlea. LW - lateral wall, SL - spiral limbus, SGNs - spiral ganglion neurons. Scale bars: 30 μm ( a, c, d ), 2μm ( b ).
Article Snippet: For immunofluorescence labeling, the following primary antibodies and secondary antibodies were used: mouse anti-MYO7A antibody (1:50) (#sc-74516, Santa Cruz), rabbit anti-HA C29F4 antibody (1:200) (#3724, Cell Signaling), rabbit anti-GJB2 antibody (1:50) (#71-0500, Fisher), goat anti-SOX2 antibody (1:50) (#AF2018, R&D Systems), rabbit anti-IBA1 antibody (1:200) (#019-19741, Wako Chemicals), donkey anti-rabbit IgG secondary antibody conjugated to Alexa Fluor 594 (1:200) (Invitrogen), donkey anti-goat IgG conjugated to Alexa Fluor 647 (1:200) (Invitrogen), donkey anti-mouse IgG conjugated to Alexa Fluor 488 (1:200) (Invitrogen), donkey anti-mouse IgG conjugated to Alexa Fluor 594 (1:200) (Invitrogen), and donkey anti-rabbit IgG conjugated to Alexa Fluor 488 (1:200) (Invitrogen).
Techniques: Control, Labeling, Knock-Out, Electron Microscopy, Plasmid Preparation, Expressing